Primary human epithelial cells were transfected with a subgenomic fragment of DNA cloned from a cervical carcinoma, containing the putative transforming genes E6 and E7 from the human papillomavirus type 16 prototype. Several immortalized cell lines were generated, all retaining tumour DNA and expressing the viral genes, suggesting that either one or both of these genes is sufficient for the immortalization of primary human genital keratinocytes.
Papillomaviruses have long been known to be the aetiological agents of benign cutaneous and mucosal epithelial lesions such as papillomas and fibropapillomas (reviewed in Pfister, 1984) . However, the detection of certain human papillomaviruses (HPVs; HPV-16 and HPV-18) with a frequency of 85 to 90 % in high grade dysplasias as well as in cervical and penile cancer biopsies Diirst et al., 1983; Gissmann et al., 1984) , has suggested a significant role for these viruses in human malignant disease. Since HPVs cannot be propagated in culture, experimental evidence for such a role has been generated only recently, primarily due to the availability of cloned viral genomes. Studies with rodent cells show that various HPVs have transforming activity (Watts et al., 1984; Yasumoto et al., 1986; Kaur & McDougall, 1987; Storey et al., 1988) , which can probably be attributed to the E6 and E7 viral genes in established cell lines (Bedell et al., 1987; Kanda et al., 1988a) , as well as primary rat cells (Kanda et al., 1988b; Matlashewski et al., 1987) . These genes are specifically retained and expressed in cell lines derived from cervical carcinomas (Schwarz et al., 1985; Smotkin & Wettstein, 1986; Yee et al., 1985) . Since HPVs are species-specific and epitheliotropic in nature, their oncogenic potential is perhaps best studied in primary human epithelial cells. Recent reports indicate that the HPV-16 genome is capable of immortalizing such cells (Diirst et al., 1987; Pirisi et al., 1987) and we have recently shown similar results with HPV-18 (Kaur & McDougall, 1988) . We now demonstrate that DNA cloned from a cervical carcinoma containing the putative transforming genes E6 and E7 from the HPV-16 prototype is sufficient for the immortalization of primary human keratinocytes.
DNA was extracted from a primary cervical carcinoma occurring in a 35-year-old woman. Southern blot data suggested that the tumour contained a single, incomplete, integrated copy of HPV-16 (Fig. 1) . A nodal metastasis removed at the same time as the primary tumour revealed the same pattern of HPV integration. The HPV-containing region was cloned using a bacteriophage lambda library, and subclones were constructed in pUC19. Southern blots, restriction maps and sequence analysis of the 11.4 kb tumour clone revealed that the central region consisted of approximately 3-4 kb of integrated papillomavirus DNA (R. Cone et al., unpublished data) . The integrated sequences extend from the mid-portion of the L1 open reading frame (ORF) through the E70RF and end within the E10RF (Fig. 2) . No duplication, 0000-8751 © 1989 SGM rearrangements or internal deletions have been detected within the integrated HPV-16 D N A based on sequence data collected from one strand of the tumour clone (R. Cone et al., unpublished data) . Flanking regions of cellular D N A were also partially sequenced and compared to published sequences in GenBank by looking for regions of homology; no significant homologies were detected by this method. The tumour clone was also evaluated for homology to known oncogenes, but no significant hybridization was seen (data not shown).
The transforming potential of the cloned tumour D N A was tested by cotransfecting 10 ~tg of it with 1 ~tg of pSV2neo D N A per 100 mm plate of subconfluent primary human epithelial cells derived from neonatal foreskin as previously described (Kaur & McDougall, 1988) . Selection in G418 yielded approximately seven colonies per ktg of pSV2neo (0.44 colonies/~tg tumour DNA). Four cell lines were established; two of these were isolated clonaUy and two were the result of pooling two to three colonies . When the parent cultures were transfected with pSV2neo alone, no G418-resistant colonies were generated; indeed in several replicate experiments, transfection with pSV2neo alone has not generated G418-resistant clones (Kaur & McDougaU, 1988) . This can probably be attributed to the fact that the primary epithelial cells used in these transfections are unable to undergo the extensive clonal proliferation required to expand a small colony of cells. This further suggests that the transfection of certain HPVs confers a proliferative potential upon human keratinocytes. The cell lines FEPE1L-8, -9, -12 and -13 were analysed by Southern blot hybridization for the presence of transfected DNA (Fig. 1) . The EcoRI enzyme used to cleave the high Mr DNA cuts at four sites within the HPV portion of the tumour DNA (two of which correspond to sites 6819 and 7454 of prototype HPV-16, and two of which are near the junctions with the flanking sequences) yielding three fragments of approximately 1-1, 0.64 and 2.1 kb which hybridize to HPV-16. These three fragments were detected in all transfected cell lines, suggesting that these cell lines contained at least one intact copy of the cloned tumour DNA, with some lines containing many more copies. The viral sequences appear to be randomly integrated into the host genome. All the cell lines have been in culture for I year to date whereas the control, carrier DNA-transfected cells senesced and were lost from culture 3 months after initiation; thus the introduction of the cloned tumour DNA immortalized primary human epithelial cells. This is consistent with previous reports which demonstrate similar activities of whole HPV-16 (Diirst et al., 1987; Pirisi et al., 1987) and HPV-18 (Kaur & McDougall, 1988) genomes in human epithelial cells, and in particular with studies using genomic DNA from cervical cancers containing HPV-16 sequences, in rat 3YI cells (Watanabe & Yoshiike, 1988) and in NIH3T3 cells (Tsunokawa et al., 1986) . Since the tumour DNA used in our studies contained only two intact HPV ORFs (E6 and E7), we conclude that one or both is sufficient for the immortalization of primary human keratinocytes although the contribution of the flanking sequences was not assessed. This conclusion is supported by observations that the E6-E7 region of HPV-18 can morphologically transform NIH3T3 cells (Bedell et al., 1987) although more recently it has become evident that the E7 gene alone of HPV-16 is capable of this activity in NIH3T3 ceils (Kanda et al., 1988b; Phelps et al., 1988) and in conjunction with activated ras in primary baby rat kidney cells (Phelps et al., 1988; Storey et al., 1988) .
Expression of viral RNA was investigated by Northern blot analysis using total cellular RNA. The blots were probed for E6 and E7 separately; the results are shown in Fig. 3 . Major transcripts of approximately 1, 3 and 6 kb were detected in the three cell lines analysed. The lack of unique transcripts exclusively hybridizing to either the E6 or E7 DNA probe suggests that hybrid transcripts must be utilized to translate both gene products when synthesized, as determined previously for HPV-6 and -11 (Chow et al., 1987) , and for HPV-16 RNA in CaSki cells (Smotkin & Wettstein, 1987) .
It was possible to determine whether the E7 message was being translated in these epithelial cell lines by radioimmunoprecipitation of [35S]cysteine-and [3SS]methionine-labelled cells using polyclonal antisera generated against a bacterial fusion protein (Firzlaff et al., 1987) . Fig. 4 shows the immunoprecipitation of the E7 protein with an Mr of approximately 20K, from all transfected epithelial lines generated in this study. Note that the E7 protein immunoprecipitated from the CaSki cell line has identical electrophoretic mobility. Attempts to immunoprecipirate the E6 protein from these cell lines have been unsuccessful. This can be attributed to a number of possible factors such as low abundance of the E6 protein in these cell lines, and/or low affinity of the antisera for the native protein. E7 is the most abundant HPV-16 and HPV-18 protein detectable in cervical cancer cell lines containing these HPV types (Seedorf et al., 1987; Smotkin & Wettstein, 1986 although HPV-16 E6 and HPV-18 E6 were also synthesized. Interestingly, Wilczynski et al. (1988) described results from 14 cervical carcinomas all of which hybridized with an E7 probe but two of these 14 tumours contained HPV DNA deleted in the E6 region.
Recently, Phelps et al. (1988) have shown that the HPV-16 E7 gene shares amino acid homologies to domains 1 and 2 of the adenovirus (Ad) E l a proteins and further shares functional similarities with the latter in that it encodes a trans-activating function for the Ad E2 early promoter, the target sequences within this promoter being identical for both Ad E l a and HPV-16 E7. Both these genes have been shown to cooperate with the activated ras oncogene in transforming primary baby rat kidney cells. Of interest is the observation that the E6 gene could not cooperate with ras in transforming these cells. These data suggest that the E7 gene alone is sufficient for immortalization.
Further studies with deletion m u t a n t s constructed from the E6 and E7 sequences will aid our understanding of the m e c h a n i s m of transformation. In conclusion, we have demonstrated that a cloned DNA sequence isolated from a cervical carcinoma containing a portion of HPV-16 is capable of immortalizing primary human epithelial cells.
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